FDA Wants Improved Products To Prevent Kidney Transplant Rejection
This article was originally published in The Pink Sheet Daily
Executive Summary
Acute antibody-mediated rejection can be treated successfully 90 percent of the time, but designing a trial for another therapy might prove difficult..